Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Akoustis Technologies | AKTS | Sep 19, 2024 | 0.07 | +15.03 |
Akoya BioSciences | AKYA | Sep 19, 2024 | 2.91 | +2.46 |
Akso Health ADR | AHG | Sep 19, 2024 | 1.14 | +5.56 |
Alamo Group | ALG | Sep 19, 2024 | 184.93 | +1.72 |
Alamos Gold | AGI | Sep 19, 2024 | 20.30 | +0.50 |
Alarm.com | ALRM | Sep 19, 2024 | 54.92 | +2.65 |
Alarum Technologies ADR | ALAR | Sep 19, 2024 | 11.59 | +2.75 |
Alaska Air Group | ALK | Sep 19, 2024 | 39.56 | -0.50 |
Alaunos Therapeutics | TCRT | Sep 19, 2024 | 2.82 | -9.62 |
Albany International | AIN | Sep 19, 2024 | 88.47 | +1.68 |
Albemarle | ALB | Sep 19, 2024 | 89.33 | +3.16 |
Albemarle ADR A Pref | ALB-A | Sep 19, 2024 | 43.31 | +3.94 |
Albertsons Companies A | ACI | Sep 19, 2024 | 18.56 | +0.22 |
Alchemy Investments Acquisition 1 | ALCY | Sep 19, 2024 | 10.87 | 0.00 |
Alchemy Investments Acquisition 1 Units | ALCYU | Sep 19, 2024 | 10.81 | -1.73 |
Alcoa | AA | Sep 19, 2024 | 34.92 | +1.69 |
Alcon | ALC | Sep 19, 2024 | 98.33 | +1.74 |
Aldeyra Therapeutics | ALDX | Sep 19, 2024 | 6.04 | +2.90 |
Alector | ALEC | Sep 19, 2024 | 6.14 | +8.87 |
Alerian Energy Infrastructure E | ENFR | Sep 19, 2024 | 28.17 | -0.22 |
Alerus Financial | ALRS | Sep 19, 2024 | 22.83 | +1.74 |
Alexander & Baldwin | ALEX | Sep 19, 2024 | 19.81 | -0.15 |
Alexanders | ALX | Sep 19, 2024 | 246.40 | +0.62 |
Alexandria Real Estate Equities | ARE | Sep 19, 2024 | 122.22 | -1.32 |
Algoma Steel Group | ASTL | Sep 19, 2024 | 9.96 | +0.15 |
Algonquin Power & Utilities | AQN | Sep 19, 2024 | 5.46 | -0.73 |
Algorhythm Holdings | RIME | Sep 19, 2024 | 0.55 | 0.00 |
Alibaba Group ADR | BABA | Sep 19, 2024 | 88.49 | +4.82 |
Alico | ALCO | Sep 19, 2024 | 29.98 | +1.52 |
Alight A | ALIT | Sep 19, 2024 | 7.47 | +3.18 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.